TCT-91 Comparison of Portico® and CoreValveTM Self-expanding Transcatheter Heart Valves for the Treatment of Failed Surgical Aortic Bioprosthesis: Insights from the Valve in Valve International Data (VIVID) Registry
نویسندگان
چکیده
منابع مشابه
Matched Comparison of Self-Expanding Transcatheter Heart Valves for the Treatment of Failed Aortic Surgical Bioprosthesis: Insights From the Valve-in-Valve International Data Registry (VIVID).
BACKGROUND Transcatheter valve-in-valve implantation is an established therapy for high-risk patients with failed surgical aortic bioprosthesis. There are limited data comparing outcomes of valve-in-valve implantation using different transcatheter heart valves (THV). METHODS AND RESULTS Patients included in the Valve-in-Valve International Data registry (VIVID) and treated with self-expanding...
متن کاملMatched Comparison of Self-Expanding Transcatheter Heart Valves for the Treatment of Failed Aortic Surgical Bioprosthesis
Background—Transcatheter valve-in-valve implantation is an established therapy for high-risk patients with failed surgical aortic bioprosthesis. There are limited data comparing outcomes of valve-in-valve implantation using different transcatheter heart valves (THV). Methods and Results—Patients included in the Valve-in-Valve International Data registry (VIVID) and treated with selfexpanding TH...
متن کاملTCT-670 Optimal Transcatheter Heart Valve Sizing in Aortic Valve in Valve Implantation: Insights from the Valve in Valve International Data (VIVID) Registry.
aortic valve area (1.33 0.41 cm2 vs. 1.52 0.5 cm2). In a multivariate analysis for elevated mean gradients within those with small surgical valves, CoreValve use (OR 0.56, CI 0.31 – 0.97, p 1⁄4 0.04), true internal diameter (OR 0.72, CI 0.59 – 0.87, p 1⁄4 0.001), THV size (OR 0.79, CI 0.65 – 0.97, p 1⁄4 0.02) and baseline regurgitation (OR 0.45, CI 0.21 – 0.93, p 1⁄4 0.03) were identified as pr...
متن کامل[Transcatheter aortic valve-in-valve implantation for failed aortic bioprosthesis].
Percutaneous valve replacement for severe aortic stenosis has been shown to be an alternative treatment option for high surgical risk patients. We describe our first valve-in-valve procedure in a patient with a degenerated aortic bioprosthesis and severe regurgitation.
متن کاملValvular Heart Disease Transcatheter Aortic Valve Replacement for Degenerative Bioprosthetic Surgical Valves Results From the Global Valve-in-Valve Registry
Danny Dvir, MD; John Webb, MD; Stephen Brecker, MD; Sabine Bleiziffer, MD; David Hildick-Smith, MD; Antonio Colombo, MD; Fleur Descoutures, MD; Christian Hengstenberg, MD; Neil E. Moat, FRCS; Raffi Bekeredjian, MD; Massimo Napodano, MD; Luca Testa, MD, PhD; Thierry Lefevre, MD; Victor Guetta, MD; Henrik Nissen, MD, PhD; José-Marı́a Hernández, MD; David Roy, MD; Rui C. Teles, MD; Amit Segev, MD; ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Cardiology
سال: 2015
ISSN: 0735-1097
DOI: 10.1016/j.jacc.2015.08.136